Author

Maria T. Abreu 1

1 University of Miami, Miller School of Medicine,

SAFETY OF USTEKINUMAB IN OLDER IBD PATIENTS (≥60 YEARS): POOLED SAFETY ANALYSIS THROUGH 5 YEARS IN CD AND 2 YEARS IN UC AND ALL APPROVED INDICATIONS

Subrata Ghosh, Elyssa Ott, Christopher Gasink, Ye Miao, Colleen W. Marano, John Lynch, Maria T. Abreu, Aline Charabaty

SUSTAINED SYMPTOM CONTROL WITH MIRIKIZUMAB IN PATIENTS WITH MODERATELY TO SEVERELY ACTIVE ULCERATIVE COLITIS IN THE LUCENT-2 MAINTENANCE TRIAL

Axel Dignass, Silvio Danese, Katsuyoshi Matsuoka, Marc Ferrante, Millie Long, Isabel Redondo, Theresa Hunter Gibble, Richard Moses, Xingyuan Li, Nathan Morris, Catherine Milch, Maria T. Abreu

TLR4-DRIVEN SPONTANEOUS TUMORIGENESIS IS MEDIATED BY MICROBIAL-INDUCED EPITHELIAL PRODUCTION OF REACTIVE OXYGEN SPECIES

Juan Burgueno, Julia Fritsch, Ana Maribel Santander, Nivis Brito, Judith Pignac-Kobinger, Gregory E Conner, irina Fernandez, Maria T. Abreu

TLR4-INDUCED DYSBIOSIS PROMOTES AN EXPANSION OF PROTEOBACTERIA THAT INCREASES SUSCEPTIBILITY TO TUMORIGENESIS

Juan Burgueno, Julia Fritsch, Ana Maribel Santander, Mukil Maruthamutu, Nivis Brito, irina Fernandez, Judith Pignac-Kobinger, Gregory E Conner, Maria T. Abreu

Item 21 - 24 / 28
1 2
3